米屈肼 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "米屈肼" in Chinese language version.

refsWebsite

Global rank Chinese rank

16web.archive.org

1^st place

7doi.org

2^nd place

23^rd place

7nih.gov

4^th place

5^th place

3grindeks.lv

low place

3seminarsincardiology.com

low place

1surechem.org

low place

1wada-ama.org

9,542^nd place

9,880^th place

1wenweipo.com

2,249^th place

74^th place

1taiwanfansclub.com

low place

1nytimes.com

7^th place

31^st place

1moex.gov.tw

low place

5,129^th place

1worldcat.org

5^th place

12^th place

1kmu.lt

low place

1clinicaltrials.gov

5,225^th place

4,888^th place

1wiley.com

222^nd place

216^th place

clinicaltrials.gov

Mildronate for Acute Ischemic Stroke. clinicaltrials.gov. [9 March 2016]. （原始内容存档于2018-02-25）.

doi.org

Sesti C, Simkhovich BZ, Kalvinsh I, Kloner RA. Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics. Journal of Cardiovascular Pharmacology. March 2006, 47 (3): 493–9. PMID 16633095. doi:10.1097/01.fjc.0000211732.76668.d2.
Liepinsh E, Vilskersts R, Loca D, Kirjanova O, Pugovichs O, Kalvinsh I, Dambrova M. Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction. Journal of Cardiovascular Pharmacology. December 2006, 48 (6): 314–9. PMID 17204911. doi:10.1097/01.fjc.0000250077.07702.23.
Hayashi Y, Kirimoto T, Asaka N, Nakano M, Tajima K, Miyake H, Matsuura N. Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction. European Journal of Pharmacology. May 2000, 395 (3): 217–24. PMID 10812052. doi:10.1016/S0014-2999(00)00098-4.
Zhu Y, Zhang G, Zhao J, Li D, Yan X, Liu J, Liu X, Zhao H, Xia J, Zhang X, Li Z, Zhang B, Guo Z, Feng L, Zhang Z, Qu F, Zhao, G. Efficacy and safety of mildronate for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial. Clinical Drug Investigation. 2013. doi:10.1007/s40261-013-0121-x.
Görgens Christian, Guddat Sven, Dib Josef, Geyer Hans, Schänzer Wilhelm, Thevis Mario. Mildronate (Meldonium) in professional sports – monitoring doping control urine samples using hydrophilic interaction liquid chromatography – high resolution/high accuracy mass spectrometry.. Drug Testing and Analysis. November–December 2015, 7: 973–979 [2016-03-08]. doi:10.1002/dta.1788. （原始内容存档于2018-02-26）.
Simkhovich BZ, Shutenko ZV, Meirena DV, Khagi KB, Mezapuķe RJ, Molodchina TN, Kalviņs IJ, Lukevics E. 3-(2,2,2-Trimethylhydrazinium)propionate (THP)--a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties. Biochemical Pharmacology. January 1988, 37 (2): 195–202. PMID 3342076. doi:10.1016/0006-2952(88)90717-4.
Fraenkel G, Friedman S. Carnitine. Vitamins Hormones. 1957, 15: 73–118. PMID 13530702. doi:10.1016/s0083-6729(08)60508-7.

grindeks.lv

Grindeks: We Believe that Meldonium Should not be Included in the List of Banned Substances in Sport. Grindeks. 2016-03-09 [2016-03-09]. （原始内容存档于2016-03-12）（英语）.
Stock news / For investors / Leading pharmaceutical company in the Baltic - «Grindeks» JSC. grindeks.lv. [9 March 2016]. （原始内容存档于2016年3月8日）.
Mildronate. Grindeks.lv. [2016-03-09]. （原始内容存档于2016-03-12）.

kmu.lt

medicina.kmu.lt

Dzerve V, MILSS I Study Group. A Dose-Dependent Improvement in Exercise Tolerance in Patients With Stable Angina Treated With Mildronate: A Clinical Trial "MILSS I" (PDF). Medicina (Kaunas). 2011, 47 (10): 544–51. PMID 22186118. （原始内容 (PDF)存档于2013年9月21日）.

moex.gov.tw

wwwc.moex.gov.tw

方進隆. 心肺耐力和有氧運動訓練: 7. （原始内容存档于2013-01-29）（中文（繁體））.

nih.gov

ncbi.nlm.nih.gov

Sesti C, Simkhovich BZ, Kalvinsh I, Kloner RA. Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics. Journal of Cardiovascular Pharmacology. March 2006, 47 (3): 493–9. PMID 16633095. doi:10.1097/01.fjc.0000211732.76668.d2.
Liepinsh E, Vilskersts R, Loca D, Kirjanova O, Pugovichs O, Kalvinsh I, Dambrova M. Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction. Journal of Cardiovascular Pharmacology. December 2006, 48 (6): 314–9. PMID 17204911. doi:10.1097/01.fjc.0000250077.07702.23.
Hayashi Y, Kirimoto T, Asaka N, Nakano M, Tajima K, Miyake H, Matsuura N. Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction. European Journal of Pharmacology. May 2000, 395 (3): 217–24. PMID 10812052. doi:10.1016/S0014-2999(00)00098-4.
Dzerve V, MILSS I Study Group. A Dose-Dependent Improvement in Exercise Tolerance in Patients With Stable Angina Treated With Mildronate: A Clinical Trial "MILSS I" (PDF). Medicina (Kaunas). 2011, 47 (10): 544–51. PMID 22186118. （原始内容 (PDF)存档于2013年9月21日）.
Simkhovich BZ, Shutenko ZV, Meirena DV, Khagi KB, Mezapuķe RJ, Molodchina TN, Kalviņs IJ, Lukevics E. 3-(2,2,2-Trimethylhydrazinium)propionate (THP)--a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties. Biochemical Pharmacology. January 1988, 37 (2): 195–202. PMID 3342076. doi:10.1016/0006-2952(88)90717-4.
Fraenkel G, Friedman S. Carnitine. Vitamins Hormones. 1957, 15: 73–118. PMID 13530702. doi:10.1016/s0083-6729(08)60508-7.

pubchem.ncbi.nlm.nih.gov

Pubchem. Mildronate. nih.gov. [2016-03-09]. （原始内容存档于2020-08-11）（英语）.

nytimes.com

All About Meldonium, the Banned Drug Used by Sharapova. New York Times. Associated Press. 2016-03-08 [2016-03-08]. （原始内容存档于2020-05-23）（英语）.

seminarsincardiology.com

Dzerve V, Matisone D, Kukulis I, Romanova J, Putane L, Grabauskiene˙V, Skarda I, Berzina D, Strautmanis J. Mildronate improves peripheral circulation in patients with chronic heart failure: results of a clinical trial (the ﬁrst report) (PDF). Seminars in Cardiology. 2005, 11 (2): 56–64. ISSN 1648-7966. （原始内容 (PDF)存档于2012-03-28）.
Vitols A, Voita D, Dzerve V. Mildronate improves carotid baroreceptor reﬂex function in patients with chronic heart failure (PDF). Seminars in Cardiovascular Medicine. 2008, 13: 6. （原始内容 (PDF)存档于2013-09-21）.
Dzerve V, Matisone D, Pozdnyakov Y, Oganov R. Mildronate improves the exercise tolerance in patients with stable angina: results of a long term clinical trial (PDF). Seminars in Cardiovascular Medicine. 2010, 16: 3. （原始内容 (PDF)存档于2013-09-21）.

surechem.org

Patent Number: 1429753.. [2012-08-16]. （原始内容存档于2013-11-05）（英语）.

taiwanfansclub.com

科普莎娃藥物：今年一月進入禁藥名單能提升耐久性. 2016-03-08 [2016-03-08]. （原始内容存档于2016年3月8日）（中文（繁體））.

wada-ama.org

Prohibited List. World Anti-Doping Agency. [2016-03-09]. （原始内容存档于2017-07-12）（英语）.

web.archive.org

Patent Number: 1429753.. [2012-08-16]. （原始内容存档于2013-11-05）（英语）.
Pubchem. Mildronate. nih.gov. [2016-03-09]. （原始内容存档于2020-08-11）（英语）.
Grindeks: We Believe that Meldonium Should not be Included in the List of Banned Substances in Sport. Grindeks. 2016-03-09 [2016-03-09]. （原始内容存档于2016-03-12）（英语）.
Prohibited List. World Anti-Doping Agency. [2016-03-09]. （原始内容存档于2017-07-12）（英语）.
莎拉波娃宣佈未通過興奮劑檢測. 文匯報. 2016-03-08 [2016-03-08]. （原始内容存档于2016-03-12）（中文）.
科普莎娃藥物：今年一月進入禁藥名單能提升耐久性. 2016-03-08 [2016-03-08]. （原始内容存档于2016年3月8日）（中文（繁體））.
All About Meldonium, the Banned Drug Used by Sharapova. New York Times. Associated Press. 2016-03-08 [2016-03-08]. （原始内容存档于2020-05-23）（英语）.
方進隆. 心肺耐力和有氧運動訓練: 7. （原始内容存档于2013-01-29）（中文（繁體））.
Dzerve V, Matisone D, Kukulis I, Romanova J, Putane L, Grabauskiene˙V, Skarda I, Berzina D, Strautmanis J. Mildronate improves peripheral circulation in patients with chronic heart failure: results of a clinical trial (the ﬁrst report) (PDF). Seminars in Cardiology. 2005, 11 (2): 56–64. ISSN 1648-7966. （原始内容 (PDF)存档于2012-03-28）.
Vitols A, Voita D, Dzerve V. Mildronate improves carotid baroreceptor reﬂex function in patients with chronic heart failure (PDF). Seminars in Cardiovascular Medicine. 2008, 13: 6. （原始内容 (PDF)存档于2013-09-21）.
Dzerve V, Matisone D, Pozdnyakov Y, Oganov R. Mildronate improves the exercise tolerance in patients with stable angina: results of a long term clinical trial (PDF). Seminars in Cardiovascular Medicine. 2010, 16: 3. （原始内容 (PDF)存档于2013-09-21）.
Stock news / For investors / Leading pharmaceutical company in the Baltic - «Grindeks» JSC. grindeks.lv. [9 March 2016]. （原始内容存档于2016年3月8日）.
Dzerve V, MILSS I Study Group. A Dose-Dependent Improvement in Exercise Tolerance in Patients With Stable Angina Treated With Mildronate: A Clinical Trial "MILSS I" (PDF). Medicina (Kaunas). 2011, 47 (10): 544–51. PMID 22186118. （原始内容 (PDF)存档于2013年9月21日）.
Mildronate for Acute Ischemic Stroke. clinicaltrials.gov. [9 March 2016]. （原始内容存档于2018-02-25）.
Görgens Christian, Guddat Sven, Dib Josef, Geyer Hans, Schänzer Wilhelm, Thevis Mario. Mildronate (Meldonium) in professional sports – monitoring doping control urine samples using hydrophilic interaction liquid chromatography – high resolution/high accuracy mass spectrometry.. Drug Testing and Analysis. November–December 2015, 7: 973–979 [2016-03-08]. doi:10.1002/dta.1788. （原始内容存档于2018-02-26）.
Mildronate. Grindeks.lv. [2016-03-09]. （原始内容存档于2016-03-12）.

wenweipo.com

news.wenweipo.com

莎拉波娃宣佈未通過興奮劑檢測. 文匯報. 2016-03-08 [2016-03-08]. （原始内容存档于2016-03-12）（中文）.

wiley.com

onlinelibrary.wiley.com

Görgens Christian, Guddat Sven, Dib Josef, Geyer Hans, Schänzer Wilhelm, Thevis Mario. Mildronate (Meldonium) in professional sports – monitoring doping control urine samples using hydrophilic interaction liquid chromatography – high resolution/high accuracy mass spectrometry.. Drug Testing and Analysis. November–December 2015, 7: 973–979 [2016-03-08]. doi:10.1002/dta.1788. （原始内容存档于2018-02-26）.

worldcat.org

Dzerve V, Matisone D, Kukulis I, Romanova J, Putane L, Grabauskiene˙V, Skarda I, Berzina D, Strautmanis J. Mildronate improves peripheral circulation in patients with chronic heart failure: results of a clinical trial (the ﬁrst report) (PDF). Seminars in Cardiology. 2005, 11 (2): 56–64. ISSN 1648-7966. （原始内容 (PDF)存档于2012-03-28）.